Although the CD8-positive T-cell LPD had no cytomorphological features of T-cell lymphoma, it was associated with a dismal outcome, despite the use of a CNS-penetrating lymphoma chemotherapy regimen. The gene discussed is CD8A; the disease is T-cell non-Hodgkin lymphoma.